Comparison between Retina Paints IPO and Sotac Pharmaceuticals IPO.
Retina Paints IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Sotac Pharmaceuticals IPO is a SME Bookbuilding proposed to list at NSE SME.
| Retina Paints IPO | Sotac Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Gretex Corporate Services Ltd. | Beeline Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | Sunflower Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Retina Paints IPO is up to ₹10.54 Cr whereas the issue size of the Sotac Pharmaceuticals IPO is up to ₹31.64 Cr. The final issue price of Retina Paints IPO is ₹30.00 per share and of Sotac Pharmaceuticals IPO is ₹111.00 per share.
| Retina Paints IPO | Sotac Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹105.00 per share | |
| Issue Price (Upper) | ₹111.00 per share | |
| Issue Price (Final) | ₹30.00 per share | ₹111.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 4000 shares | 1200 shares |
| Fresh Issue Size | 35,12,000 shares | 28,50,000 shares |
| Fresh Issue Size (Amount) | up to ₹10.54 Cr | up to ₹31.64 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 35,12,000 shares | 28,50,000 shares |
| Issue Size Total (Amount) | up to ₹10.54 Cr | up to ₹31.64 Cr |
Retina Paints IPO opens on Apr 19, 2023, while Sotac Pharmaceuticals IPO opens on Mar 29, 2023. The closing date of Retina Paints IPO and Sotac Pharmaceuticals IPO is Apr 24, 2023, and Apr 03, 2023, respectively.
| Retina Paints IPO | Sotac Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | Mar 28, 2023 | |
| Issue Open | Apr 19, 2023 | Mar 29, 2023 |
| Issue Close | Apr 24, 2023 | Apr 03, 2023 |
| Basis Of Allotment (Tentative) | Apr 27, 2023 | Apr 10, 2023 |
| Initiation of Refunds (Tentative) | Apr 28, 2023 | Apr 11, 2023 |
| Credit of Share (Tentative) | May 02, 2023 | Apr 12, 2023 |
| Listing date (Tentative) | May 03, 2023 | Apr 13, 2023 |
| Anchor Lockin End date 1 | May 10, 2023 | |
| Anchor Lockin End date 2 | Jul 09, 2023 |
Retina Paints IPO P/E ratio is , as compared to Sotac Pharmaceuticals IPO P/E ratio of 132.14.
| Retina Paints IPO | Sotac Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 80.70 | 84.63 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 59.28 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 132.14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹122.66 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 6.38% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 19.03% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.74 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Retina Paints IPO Retail Individual Investors (RII) are offered 17,56,000 shares while in Sotac Pharmaceuticals IPO retail investors are offered 17,56,000 shares. Qualified Institutional Buyers (QIB) are offered in Retina Paints IPO and 5,70,000 shares in Sotac Pharmaceuticals IPO.
| Retina Paints IPO | Sotac Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reserveration | 8,53,200 shares | |
| Market Maker Reserveration | 1,88,000 shares | 1,50,000 shares |
| QIB | 5,70,000 shares | |
| NII | 17,56,000 shares | 4,28,400 shares |
| RII | 17,56,000 shares | 9,98,400 shares |
| Employee | ||
| Others | ||
| Total | 35,12,000 shares | 28,50,000 shares |
Retina Paints IPO subscribed 8.29x in total, whereas Sotac Pharmaceuticals IPO subscribed 1.60x.
| Retina Paints IPO | Sotac Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 1.00x | |
| NII (times) | 6.10x | 4.04x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 10.41x | 0.91x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 8.29x | 1.60x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
